SCHEMBL23490760

SCHEMBL23490760

CNc1ccc(C(=O)OC(C)(C)C)cc1NCCOC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 4/20 0.51
▸ ALDH1A1 P00352 4/20 0.47
▸ MAPT P10636 3/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ HCAR3 P49019 2/20 0.45
▸ ALOX15 P16050 1/20 0.42
▸ MAPK14 Q16539 1/20 0.38
▸ HPGD P15428 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ GABRA1 P14867 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23287003 0.89 PTGER4 (0.53) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL23286926 0.88 PTGER4 (0.56) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL23287036 0.85 PTGER4 (0.47) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL23273555 0.85 PTGER4 (0.57) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL23287173 0.82 PTGER4 (0.70) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL23286252 0.81 MAPT (0.60) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL29738069 0.81 MAPT (0.60) PTGER4ALDH1A1MAPTRAB9AHCAR3
SCHEMBL23287088 0.78 SLC7A5 (0.40) PTGER4ALDH1A1MAPTALOX15HPGD
SCHEMBL23287050 0.76 ALOX15 (0.39) PTGER4ALDH1A1MAPTRAB9AALOX15
SCHEMBL24083653 0.75 ALOX15 (0.43) ALDH1A1RAB9AALOX15SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702404-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2023-07-18 — — US disclosed
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702404-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 PTGER4 996/4885ALDH1A1 3556/4885MAPT 3314/4885
US-20210171499-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 PTGER4 996/4885ALDH1A1 3556/4885MAPT 3314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback